News

From spring conferences to recently declared food-borne outbreaks, April was a busy month full of infectious disease news.

Timothy Minogue, PhD, discusses his presentation on miRNAs for Ebola and the capabilities of the host profiling side and the pathogen-derived side.

A team of investigators is examining why some transgender women taking hormones may need higher levels of PrEP medication.

The CDC reports 704 cases of measles have been confirmed to date since January 1, 2019, across 22 states.

Experts from the fields of microbiology and infectious disease share their biggest takeaways and highlights from ECCMID 2019.

The growth of opioid addiction in the United States has led to a significant convergence between substance use disorders and infectious diseases. Physicians who specialize in the latter need to take note.

An intervention involving improved communication and antibiotic timeouts in nursing homes reduced the days of antibiotic therapy, according to a recent study.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of April 21, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The aggregated average HAI rates before and after discontinuing contact precautions were 0.14 and 0.15 MRSA HAI/1000 patient days, 0.06 and 0.04 VRE HAI/1000 patient days, and 0.04 and 0.03 MRSA LabID events/100 admissions.

Investing in biocontainment units has paid off in several ways for Johns Hopkins.

A 2017 pediatric tetanus infection case in a child who was not vaccinated led to nearly 2 months of hospitalization and more than $800,000 in medical costs.

The rate of health care-associated influenza cases per season decreased from a median of 16.8 cases pre-policy rollout to 5.2 cases post-policy rollout at a large pediatric hospital.

Non-sporicidal cleansers are commonly used to disinfect surfaces in the hospital rooms of patients with C auris colonization or infection, but are they efficacious?

Vaccination against respiratory syncytial virus before birth or a dose of monoclonal antibody at birth may address an increased risk of hospitalization for RSV-associated illnesses in infants exposed to HIV.

Health officials hypothesize that deli sliced meats and cheeses are responsible for the infections, yet a common source has not been identified at this time.

Investigators in New York state, which has the largest burden of C auris colonization in the US, used 12 point prevalence surveys at 6 nursing homes to identify 60 cases and 218 controls.

In a South Korean study of contaminated stethoscopes, 23% were confirmed to have at least 1 potential multidrug-resistant bacterial pathogen.

A multistate outbreak of Salmonella Newport has been linked to raw tuna products distributed by Jensen Tuna.

Corrine Maurice, PhD, discusses her talk at the European Congress of Clinical Microbiology and Infectious Disease (ECCMID 2019) on the interactions between host, bacteria, gut microbiota, and bacteriophages.

Johns Hopkins symposium will highlight new challenges and approaches in the fight against the mosquito-borne disease.

Ben Berkhout, PhD, discusses if CRISPR/Cas9 will be a new antiviral strategy for the eradication of HIV.

Here are the top takeaways from the European Congress of Clinical Microbiology and Infectious Disease 2019 meeting.

Thus far, 626 cases of measles have been recorded in 2019 and health officials anticipate that case counts will soon surge past the record of 667 cases documented during all of 2014.

Medical Economics report finds just 22% of physicians reported a rise in compensation during 2018.

A new study may help to explain how bacteria present at low levels in healthy human mouths can persist for months and cause hospital outbreaks of drug-resistant infections.

At ECCMID 2019, László Majoros, MD, PhD, spoke about rezafungin’s activity against common and rare Candida species in vitro.

A new strategy that enforces a type of cell division in memory T cells could lead to longer-lasting immune protection in patients.

Missing visits is a warning sign that patients may discontinue PrEP, according to a recent study that found only 38% of participants remained in treatment over 12 months.